FDA Drugs recall ·
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal… recall
This is an FDA Class I recall — the most serious type.
- Recall number
- D-0553-2026
- Date
- (initiated April 24, 2026)
- Company / brand
- Wisconsin Pharmacal Company
N168w22223 Main St, Jackson, WI, United States - Category
- Drugs › Class I
- Classification
- Class I
- Status
- Ongoing
- Units affected
- 690 tubes
- Hazard tags
- Sterility Microbial contamination
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Why was it recalled?
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot #: 1024088, Exp 11/30/2026
Distribution
USA Nationwide and Bahamas
What does Class I mean?
Class I is the most serious FDA recall class: there is a reasonable probability that using or being exposed to the product will cause serious adverse health consequences or death.
Source: FDA (drugs), recall D-0553-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.